Concepedia

Lua Wilkinson

LW

Statistics

Publications

4

Citations

100

H-Index

4

Active since

2020

Affiliations

Novo Nordisk (United States)(Current)

University of Alabama at Birmingham

Lua Wilkinson is an author at Novo Nordisk (United States) specializing in insulin resistance, weight loss, and medicine.

ORCID

Publications per year

2020–2024

4

Publications

4

Development and validation of a model for predicting incident type 2 diabetes using quantitative clinical data and a Bayesian logistic model: A nationwide cohort and modeling study

Lua Wilkinson, Nengjun Yi, Tapan Mehta et al. · PLoS Medicine · 2020 · 43 citations · Full text

, , +17

Weight variability during self-monitored weight loss predicts future weight loss outcome

Leora Benson, Fengqing Zhang, Hallie Espel‐Huynh et al. · International Journal of Obesity · 2020 · 19 citations

, , +13

Effect of semaglutide 2.4 mg once weekly on 10‐year type 2 diabetes risk in adults with overweight or obesity

Lua Wilkinson, Thomas Holst‐Hansen, Peter Nørkjær Laursen et al. · Obesity · 2023 · 19 citations · Full text

, , +17

Cardiometabolic Disease Staging and Major Adverse Cardiovascular Event Prediction in 2 Prospective Cohorts

Carrie R. Howell, Li Zhang, Tapan Mehta et al. · JACC Advances · 2024 · 19 citations · Full text

, , +17

1–4 of 4